TG Therapeutics | TGTX - Ebitda





Ebitda تغيير تاريخ
AbbVie USD 5.37B 1.85B 2025-12
Alaunos Therapeutics USD -21.02M 1.33M 2021-03
Amgen USD 5.14B 775M 2025-12
Ardelyx USD 6.02M 447K 2025-12
Arrowhead Research USD 57.17M 7.03M 2025-12
Bayer EUR 4.45B 2.49B 2026-03
Biogen USD 649.7M 76.5M 2026-03
Corcept Therapeutics USD 4.2M 6.5M 2025-12
Curis USD -12.3M 231K 2023-09
Gilead Sciences USD 3.02B 1.01B 2025-12
Infinity Pharmaceuticals USD -10.01M 1.39M 2023-06
J&J USD 7.19B 2.32B 2025-12
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Novartis USD 5.3B 530M 2026-03
Novavax USD 19.36M 190.79M 2025-12
PTC Therapeutics USD -70.99M 91.62M 2025-12
Puma Biotechnology USD 729K 11.36M 2024-06
Regeneron Pharmaceuticals USD 1.2B 718.4M 2025-12
Roche Holding CHF 12.68B 2.36B 2024-06
TG Therapeutics USD 51.69M 19M 2025-12
Vertex Pharmaceuticals USD 1.19B 195.3M 2026-03